Inhibitors of islet amyloid polypeptide fibrillogenesis, and the treatment of type-2 diabetes

By Louise A. Scrocchi  

Letters in Peptide Science, Vol. 10, Iss. 5, 2003-01 ,pp. : 545-551

Springer Publishing Company

Access to resources Recommend Favorite

Design of Peptide-based Inhibitors of Human Islet Amyloid Polypeptide Fibrillogenesis

By Scrocchi L.A.   Chen Y.   Waschuk S.   Wang F.   Cheung S.   Darabie A.A.   McLaurin J.   Fraser P.E.  

Journal of Molecular Biology, Vol. 318, Iss. 3, 2002-05 ,pp. : 697-706

Academic Press

Access to resources Recommend Favorite

Islet Amyloid Polypeptide and Diabetes

By  

Current Protein and Peptide Science, Vol. 14, Iss. 4, 2013-06 ,pp. : 330-337

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of a Penta- and Hexapeptide of Islet Amyloid Polypeptide (IAPP) with Amyloidogenic and Cytotoxic Properties

By Tenidis K.   Waldner M.   Bernhagen J.   Fischle W.   Bergmann M.   Weber M.   Merkle M-L.   Voelter W.   Brunner H.   Kapurniotu A.  

Journal of Molecular Biology, Vol. 295, Iss. 4, 2000-01 ,pp. : 1055-1071

Academic Press

Access to resources Recommend Favorite

Renal Elimination of Islet Amyloid Polypeptide

By Leckstrom A.   Bjorklund K.   Permert J.   Larsson R.   Westermark P.  

Biochemical and Biophysical Research Communications, Vol. 239, Iss. 1, 1997-10 ,pp. : 265-268

Elsevier

Access to resources Recommend Favorite